Scarica l'app Stockscreener
32.57
1.40%
0.45
Cue Biopharma Inc Borsa (CUE) Ultime notizie
CUE|Cue Biopharma Inc|Price:32.120|Chg%:-0.970 - TradingKey
Cue Biopharma Inc (CUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enterprise value to EBITDA forward of Cue Biopharma, Inc. – NASDAQ:CUE - TradingView
Cue Biopharma Inc (CUE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CUE Stock Jumps Over 100% After Hours — What’s Driving The Rally? - Stocktwits
Cue Biopharma Inc (CUE) Income Statement - TradingKey
Cue Biopharma Inc (CUE) Balance Sheet - TradingKey
CUE Stock On Track For Best Day In History — Why Is Retail Optimistic? - Stocktwits
Cue Biopharma, Inc. Revenue Breakdown – NASDAQ:CUE - TradingView
Cue Biopharma Inc (CUE) Cash Flow - TradingKey
Cue Biopharma Inc (CUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to EBITDA forward of Cue Biopharma, Inc. – DUS:1UC0 - TradingView
Cue Biopharma (CUE) Stock Forecast & Analyst Ratings - Moomoo
Cue Biopharma, Inc. announced that it has received $49.999926 million in funding from Cormorant Asset Management, LP, Threadneedle Asset Management Limited - marketscreener.com
Cue Biopharma (CUE) completes $49,999,927 Reg D Rule 506(b) raise - Stock Titan
ETFs Investing in Cue Biopharma, Inc. Stocks - TradingView
Cue Biopharma (CUE) Q2 2024 earnings summary - Quartr
Form 4 Cue Biopharma For: 15 July By Investing.com - Investing.com Nigeria
Cue Biopharma (CUE) awards RSUs and stock options to CMO Borie - Stock Titan
Cue Biopharma (NASDAQ: CUE) CMO Dominique Borie files initial Form 3 - Stock Titan
Cue Biopharma appoints CMO - The Pharma Letter
Cue Biopharma (CUE) Edges Higher Amid Tight Trading RangeSingle Stock ETF - dars.gov.et
Cue Biopharma names Dominic Borie as CMO and head of R&D - MSN
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight - GlobeNewswire Inc.
Cue Biopharma names Dominic Borie as chief medical officer By Investing.com - Investing.com Australia
Cue Biopharma names Dominic Borie as chief medical officer - Investing.com
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development - The Manila Times
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH - RTTNews
Immunology veteran Dominic Borie to steer Cue Biopharma’s drug pipeline - Stock Titan
Enterprise value to EBIT forward of Cue Biopharma, Inc. – MUN:1UC0 - TradingView
Price to earnings forward of Cue Biopharma, Inc. – MUN:1UC0 - TradingView
Enterprise value to revenue forward of Cue Biopharma, Inc. – MUN:1UC0 - TradingView
Form 4 Cue Biopharma For: 10 July By Investing.com - Investing.com India
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Garzone Pamela - Moomoo
Cue Biopharma (CUE) awards 21,800 time-vested RSUs to director Garzone - Stock Titan
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Camardo Daniel A. - Moomoo
Cue Biopharma (CUE) awards 21,800 restricted stock units to board director - Stock Titan
Cue Biopharma (CUE) director Sarraf Pasha receives 21,800 RSU equity award - Stock Titan
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Meehan Viola Mong - Moomoo
Cue Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Meluzio Michael Vincent - Moomoo
Cue Biopharma (CUE) awards 40,942 RSUs and 40,942 PSUs to accounting chief - Stock Titan
Cue Biopharma (CUE) awards 109,178-share RSU and PSU package to legal chief - Stock Titan
Cue Biopharma (CUE) CEO Shao-Lee Lin awarded 327,537-share RSU and PSU package - Stock Titan
Cue Biopharma Announces $50 Million Private Placement - TipRanks
Cue Biopharma Raises ~$50 Million in Private Placement With Cormorant, Columbia Threadneedle - TradingView
Cue Biopharma (Nasdaq: CUE) secures $50M private placement and grants over 1M RSUs - Stock Titan
Cue: The Market Is Paying $86M For A Drug It Doesn't Own (NASDAQ:CUE) - Seeking Alpha
Cue Biopharma Shares Rise on $50 Million Private Placement Pricing - Moomoo
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):